Smith & Nephew (LON:SN) Price Target Lowered to GBX 1,290 at JPMorgan Chase & Co.

Key Points

• JPMorgan lowered Smith & Nephew’s price target to GBX 1,290 from GBX 1,438 while maintaining a “neutral” rating, implying roughly 15% upside from the current share price.
• Analyst sentiment remains mixed, with three Buy ratings and six Holds; MarketBeat reports a consensus rating of “Hold” and an average target price of GBX 1,172.56.
• Smith & Nephew shares opened at GBX 1,122, down 6.3%, with the company valued at approximately £12.30 billion and trading at a price-to-earnings ratio of 40.40.

Smith & Nephew (LON:SN - Get Free Report) had its price objective cut by analysts at JPMorgan Chase & Co. from GBX 1,438 to GBX 1,290 in a research report issued on Thursday,London Stock Exchange reports. The firm currently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 14.97% from the stock's current price.

A number of other research firms have also weighed in on SN. Jefferies Financial Group reiterated a "buy" rating and set a GBX 1,500 target price on shares of Smith & Nephew in a report on Wednesday. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a GBX 1,400 price target on shares of Smith & Nephew in a report on Thursday, July 30th. Shore Capital Group reaffirmed a "buy" rating and set a GBX 1,000 price target on shares of Smith & Nephew in a research report on Tuesday, July 21st. Citigroup cut Smith & Nephew to a "buy" rating in a report on Friday, July 10th. Finally, Royal Bank Of Canada reiterated a "sector perform" rating and issued a GBX 1,350 price objective on shares of Smith & Nephew in a report on Monday, June 29th. Three investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of GBX 1,172.56.

Smith & Nephew Stock Down 6.3%

Shares of Smith & Nephew stock opened at GBX 1,122 on Thursday. The stock has a 50-day moving average price of GBX 1,135.98 and a two-hundred day moving average price of GBX 1,194.09. The company has a market cap of £12.30 billion, a price-to-earnings ratio of 40.40, a PEG ratio of 0.46 and a beta of 0.69. The company has a debt-to-equity ratio of 73.07, a quick ratio of 0.84 and a current ratio of 2.14.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source